Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | P-cure P-cure is a company that provides a gantry-less proton therapy system that fits any radiation oncology department. | Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | |
Founding Date | Founding Date 2013 | Founding Date 2007 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations København, DK HQ | Locations Shilat HQ Akron, US | Locations Tucson, US HQ |
Employees | Employees 7 | Employees 442% increase | Employees 1220% increase |
P-cure is a company that provides a gantry-less proton therapy system that fits any radiation oncology department.
View companyMicrovascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company